Latar belakang: Jaringan tumor biasanya mengalami hipoksia karena terganggunya suplai oksigen ke daerah tersebut. Respons adaptasi terhadap keadaan hipoksia jaringan kanker diperantarai oleh 
The incidence of breast cancer was ranked the highest of cancer in Indonesia in 2012. 1 Cancer develops if apoptosis is disturbed and cell growth is faster and live longer than normal. In otherwords, tumor growth is supported by the ability to avoid apoptosis. 2 The tumor blood vessels are structurally and functionally abnormal causing temporarily irregular of blood flow which leads to hypoxic environment in the tumor tissue, and finally induce the increase of hypoxia-inducible factor-1α (HIF-1α) protein stability in various tumor tissues. 3 HIF-1α is a transcription factor of many target genes that functions in hypoxia adaptation response. Protein HIF-1 has two sub-units, HIF-α and β. HIF-1α domain contains basic-Helix-Loop-Helix (bHLH) at the N-terminal, two domains Per-ARNT-Sim (PAS), an oxygen-dependent degradation domain (ODD) which mediates the stability of HIF-1 dependent oxygen, and a transactivation domain (TAD) at the C-terminal (C-TAD). 4 The presence of oxygen causes prolyl hydroxylase (PHD) enzyme to catalyze the hydroxylation of proline residues 402 and 564 in the ODD domain of HIF-1α protein in cytoplasm. 5 The hydroxylated HIF-α is recognized by von Hippel Lindau (VHL) protein thus bind to it. The HIF-α protein that binds to vHL can be degraded through ubiquitination. 4 During hypoxic condition, the hydroxylation of HIF-1α protein does not occur due to the lack of oxygen as a substrate for PHD thus increasing the stability of HIF-1α in the cytoplasm. 6 The stabilized form of HIF-1α protein will translocate from the cytoplasm to the nucleus, where it heterodimerizes with HIF-1β. The HIF-α/HIF-β complex binds to hypoxic responsive elements (HREs) sequence located in the upstream of the target genes of HIF-α protein leading to induction of the expression of target genes which play some roles in tumor growth, such as erythropoietin (EPO), vascular endothelial growth factor (VEGF), glucose transporter-1, 3 ( GLU1, 3) and glucose transporter 1 (GLUT-1), carbonic anhydrase-9 (CA IX) and lactate dehydrogenase-A (LDHA).
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Besides increasing the survival of tumor cells in hypoxic conditions, HIF-1α is also involved in apoptosis of tumor cells. Ardyanto found that the induction of HIF-1α by CoCl 2 for 6 hours in gastric carcinoma cell line increased the HIF-1α protein expression leading to decreased and increased in apoptosis and proliferation, respectively. 8 
HIF-1α
protein can affect the release of cytochrome-c through the p53 pathway and BNIP3. 9 Various signals that induce apoptosis will converge in mitochondrial as a releaser of cytochrome-c and then will activate the caspase cascade that leads to apoptosis.
Several studies have shown that HIF-1α can inhibit apoptosis pathway by increasing the expression of inhibitors of apoptosis proteins such as survivin. 10 Peng, et al 11 found that HIF-1α protein can activate the transcription of survivin gene in breast cancer cells by binding directly to the promoters of genes survivin. Survivin inhibits the conversion of procaspase 9 to the active form. It has been demonstrated that survivin has become a target for cancer treatment, in which, inhibition of its expression was shown to increase the effectiveness of chemotherapy and chemoradiation. 12 Induction of HIF-1α by CoCl 2 with various concentrations has been performed on variety of cells, including tumor cells. Cobalt can inactivate PHD by binding to the iron binding site of PHD because of its structure similar to the iron (Fe
2+
). The result is that HIF-1α does not undergo hydroxylation by PHD and is not degraded by ubiquitin, which resulted in increased stability of HIF-1α. 13 The aim of this study is to analyze the role of HIF-1α on breast cancer cells survival through pro-apoptosis cytochrome-c and anti-apoptosis regulation.
METHODS

Cell culture and treatments
Breast cancer cell line T47D was used as a sample because it represents most of the breast cancer characteristics, i.e. derived from ductal carcinoma breast cancer cells, estrogen and progesteron receptor positive, and p53 mutan. T47D cells were induced by CoCl 2 then we examined the expression of HIF-1α, cell viability, cytochrome-c and survivin.
HIF induction
T47D cells were grown in 24-well plate with a number of 2.5 X 10 4 cells in each well and maintained in 1 mL of medium Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS), 100 U/mL penicillin, 100 ug/mL streptomycin, and 292 ug/mL L-glutamine at 37°C, 5% CO 2 for 24-48 hours. After reaching 80% confluent, the medium was discarded and then the cells were induced with CoCl 2 250 µM or 500 µM dissolved in DMEM without FBS for 2, 6, 24 or 48 hours. T47D cells with the treatment but without CoCl 2 induction was used as a control. After induction by CoCl 2 , cells were harvested and were analyzed for HIF expression, cell viability and cytochrome-c.
ELISA HIF-1α
Cells that have been induced by CoCl 2 were examined for HIF-1α protein by ELISA using Human/Mouse HIF-1α Total Immunoassay (R&D Systems) reagen kit.
HIF-α mRNA and survivin mRNA RT-PCR
RNA samples were isolated and amplified using SYBR-Green kit (BioRad). The HIF-1α primer sequences used were 5'-CCA GCA ACT TGA TGA TGA GG-3 '(forward) and 5'-TTG ATT GAG TGC AGG GTC AG-3' (reverse) (designed by Dr.dr. Novi Silvia Hardiany, MBiomed) whereas Survivin primer sequences used were 5'-GCC AGA CAT TGA AGA CGA CCC GGA-3 '(forward) and 5'-CGC CGG TCG ATG GCA ACT TT-3' (reverse).
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Cytochrome-c analysis
Cytochrome-c concentration was analyzed using sandwich ELISA technique by Human Cytochrome-c Immunoassay kit (Quantikine ®).
Viability assay by MTS method
The number of living cells after induction with CoCl 2 was measured by MTS method using CellTiter 96R Aqueous Non-Radioactive Cell Proliferation Assay (a) (Promega). Reagent used is a solution of a substance containing tetrazolium [3-(4,5-dimethylthiazol-2-yl)-5-(3carboxymethoxyphenyl)-2 -(4-sulfophenyl)-2H-tetrazolium, inner salt; MTS(a)] and a metabolic binding reagent (phenazines methosulfate; PMS).
Statistical analysis
The results of each measurement were analyzed using ANOVA method for significance and with Pearson correlation test for correlation analysis. Both of them were analyzed using statistical program SPSS 11.5. Statistical significance was set at p < 0.05.
RESULTS
T47D cultures
T47D cells obtained from Dr.rer.nat. Marselina Irasonia Tan, MS (School of Life Sciences, ITB) was grown and propagated in DMEM medium with 10% FBS (Figure 1 ).
Figure 1. T47D cells were cultured in DMEM medium
Optimization of CoCl 2 incubation
Optimization of CoCl 2 induction was performed on T47D cells. T47D cells were induced by 500 µM CoCl 2 for 2, 6, 24, and 48 hours to determine the most optimal time for incubation. After induction with various period of time, it was concluded that the concentration of HIF-1α protein were highest in six hours after incubation. CoCl 2 incubation more than six hours showed a decreased in HIF-1α protein concentrations (Figure 2 ). Based on this result, the induction of HIF-1α were conducted by six hour incubation of 500 µM CoCl 2 .
Protein HIF-1α analysis HIF-1α protein concentration increased in line with increased concentrations of CoCl 2 given. However there is no significant difference between the ratio of the concentration of HIF-1α induced by 250 µM and 500 µM CoCl 2 with the control sample ( Figure 3 ). Strong positive correlation was found between the increase in the concentration of CoCl 2 and the concentration of HIF-1α although the difference did not reach statistically significant (Pearson, r = 0.971, p = 0.154). 
Cytochrome-c analysis
Cytochrome-c concentration increased in line with 
Survivin expression analysis
Survivin mRNA expression was increased with increased concentrations of CoCl 2 . Significant difference was found between the expression of survivin mRNA of control cells and cells induced by 250 µM CoCl 2 (t-test, p = 0.005) and 500 µM CoCl 2 , respectively (t-test, p = 0.024) ( Figure 6 ). In addition, there was a strong positive correlation between survivin mRNA expression and HIF-1α mRNA expression (Pearson, r = 0.994). There was no significant correlation between HIF-1α protein concentration and cell viability.
DISCUSSION CoCl 2 induction, HIF-1α, and cytochrome-c
From the present study, we found a strong positive correlations between the increase of CoCl 2 concentration and HIF-1α protein as well as mRNA expression in T47D cells. These results were in consistent with the study conducted by Hendrawan, et al 15 which found that the gene expression of HIF-1α myocardial cells increased gradually in line with the duration of hypoxia and reached a peak at day 21. We also found a strong positive relationship between the concentration of HIF-1α protein and of cytochrome-c in the cytoplasm of T47D cells induced by CoCl 2, and between the expression of HIF-1α mRNA and the concentration of cytochrome-c. These results are consistent with the study of Ardyanto which show that the apoptotic index of myocardial cells increases with duration of hypoxia, although there is no significant association between increased expression of HIF-1α with the increase in the apoptotic index.
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HIF-1α protein can induce cell apoptotic through two pathways, the p53 pathway and Bcl-2/ adenovirus E1B 19 kDa-interacting protein 3 (BNIP3) pathway. P53 protein is a tumor suppressor protein and a transcription factor of various pro-apoptotic genes. P53 protein can be induced by many toxic substances, including gamma radiation, ultraviolet, genotoxic drugs and oxidative stress. Meanwhile, BNIP3 is a proapoptotic protein of Bcl-2 proteins family which have only BH3 domain.
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HIF-1α protein can increase the stability of p53 protein. The increase of p53 protein stability thus inhibit the anti-apoptotic proteins Bcl-2 and Bcl-XL so that the pro-apoptotic proteins Bax and Bak can be freely increase the permeability of mitochondrial cell membrane. The increased of mitochondrial cell membrane permeability will increase the cytochrome-c removal from mitochondrial intermembrane space to cytoplasm. 17 The increase of BNIP3 expression would inhibit anti-apoptosis Bcl-2 and Bcl-XL so that the pro-apoptotic protein Bax and Bak can induce the removal of cytochrome-c from mitochondrial intermembrane space to cytoplasm. The cytochrome-c in the cytoplasm will bind to Apaf-1 protein to form apoptosome body. Apoptosome body will then activate caspase-9, and the active caspase-9 will activate the apoptotic executor caspase-3. Once activated, the apoptotic executor caspase-3 will induce apoptosis.
Despite causing an increase in pro-apoptotic protein cytochrome-c in cytoplasm, the excessive expression of HIF-1α in breast carcinoma also strongly associated with poor clinical prognosis. The increased expression of HIF-1α in breast cancer also associated with increased in tumor progression which characterized by excessive vascularization, tumor invasion, tumor size, tumor metastasis, tumor stage and degree of histopatologic.
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HIF-1α and survivin
There is strong positive correlation between HIF-1α protein concentration and survivin mRNA expression in this study. We also found strong positive correlation between HIF-1α mRNA expression and survivin mRNA expression.
Strong positive correlation between the expression of HIF-1α and mRNA survivin expression showed that HIF-1α play a role in increasing the expression of survivin which can cause the inhibition of apoptosis leading to the increase of tumor growth. Peng, et al 11 found that HIF-1α protein can activate the transcription of survivin gene in breast cancer cell line MCF-7 by binding directly to the promoters of survivin genes. The increase of HIF-1α gene expression can increase the promoter activity of survivin in gene in breast cancer cell line MCF-7, but not in normal breast cell line MCF-10A. The results of this study indicate that the increased expression of HIF-1α gene is associated with increased expression of survivin in breast cancer cell line T47D.
Expression of survivin appears to have a very large correlation with the expression of Bcl-2 (antiapoptotic protein) and the decreased apoptotic index in breast cancer. 19 Increased survivin expression is also associated with an increased risk of recurrences, locoregional lymph node invasion and metastasis. 10 Survivin can inhibit caspase-9 activation by cytochrome-c. The consequence of this inhibition on caspase-9 activation is that the apoptotic executor caspase-3 will be stopped so that the apoptosis will be inhibited.
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The inhibition of HIF-1α mRNA in lung adenocarcinoma cell line and colorectal carcinoma cell line downregulates the expression of survivin mRNA. 20 It is also found that inhibition of survivin in vitro and in vivo suppressed the potential growth tumor and increased the sensitivity of tumor cells to chemotherapy agents and also inhibited the occurrence of angiogenesis. Inhibition of survivin mRNA expression also halted the growth of mice lymphoma tumor cells. 21 It has been known that the increased stability of HIF affects mainly the increase in survivin gene expression compared to the release of cytochrome-c into the cytoplasm. Inhibition of HIF is expected to suppress anti-apoptotic protein survivin so that apoptotic will continue. Inhibition of HIF-1α would also suppress the release of cytochrome-c into the cytoplasm which causes apoptosis does not occur so that cancer cells will continue to proliferate. This cancer cells proliferation can be inhibited by administration of cytotoxic chemotherapy drugs. 22 Sekarutami 23 have shown that patients with cervical cancer who received combination of chemoradiotherapy plus hypoxia response modifier therapy (KON) showed the highest response (90.9%) compared to patients who only received chemoradiotherapy (69.2%) or radiotherapy plus KON (63.6%).
HIF and cell viability
Induction of HIF-1α in this study did not affect the viability of T47D cells. Analysis about the role of HIF-1α towards the pro-apoptotic protein cytochrome-c and anti-apoptotic survivin in previous studies were conducted in separate studies. In addition, the role of HIF-1α toward pro and anti-apoptotic proteins has never been studied on T47D breast cancer cells line, but rather on the breast cancer cell line MCF-7. This study integrates the two factors: the role of HIF-1α towards pro-apoptotic cytochrome-c and antiapoptosis in the same cells, ie breast cancer cells line T47D. Thus, the role of HIF-1α protein with respect to the balance regulation between proapoptotic and anti-apoptotic was directly visible from no differences in cells viabilities before and after HIF-1α induction.
The increasing of pro-apoptotic protein cytochrome-c after induction of HIF-1α by CoCl 2 administration in this study succeeded in inhibiting the increase of T47D breast cancer cells viabilities. Meanwhile, the increasing of survivin after induction of HIF-1α by CoCl 2 was suceeded to inhibit T47D cells apoptosis. The end result of pro-apoptotic protein cytochrome-c and antiapoptotic survivin expression regulation by HIF-1α is the balance of apoptotic pathway, as shown by the absence of differences in the T47D cells viabilities before and after HIF-1α induction by CoCl 2 .
Based on the above results, it can be concluded that CoCl 2 induction caused an increase of HIF-1α that were correlated with the increased of pro-apoptotic cytochrome-c protein as well as anti-apoptotic survivin mRNA level. Therefore, the induction of HIF-1α by CoCl 2 did not cause changes in breast cancer cell viability.
In conclusion, this study shown that HIF-1α induction have no effects on breast cancer cell line T47D viabilities because of the balance regulation between pro-apoptosis expression cytochrome-c and anti-apoptosis survivin. Therefore, our results motivate careful assessment of the possibility of HIF-1α as a target therapy in cancer.
